NDC 60977-141
Protopam Chloride
Pralidoxime Chloride
Protopam Chloride is a Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is Pralidoxime Chloride.
| Product ID | 60977-141_4e43b2a7-a8e6-462c-af8f-49aba0ed8148 |
| NDC | 60977-141 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Protopam Chloride |
| Generic Name | Pralidoxime Chloride |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Marketing Start Date | 1965-03-10 |
| Marketing Category | NDA / NDA |
| Application Number | NDA014134 |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | PRALIDOXIME CHLORIDE |
| Active Ingredient Strength | 1 g/20mL |
| Pharm Classes | Cholinesterase Reactivator [EPC], Cholinesterase Reactivators [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |